Pfizer’s candidate oral pill for COVID-19 ‘reduces death rate by 89%’

Pfizer announced on Friday that its experimental oral pill for COVID-19, PAXLOVID, helps reduce the rate of hospitalisation and death by 89 percent. The development is part of…